Children who wheeze are at risk of developing damage that will affect their lung function by the age of 6 years, according to researchers at CHU Sainte-Justine Hospital and the University of Montreal. These appear to be persistent, ...
May 7, 2014
0
0
(HealthDay)—A panel of expert advisors to the U.S. Food and Drug Administration on Friday voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status.
May 5, 2014
0
0
(HealthDay)— Many parents know that allergies are seasonal, but fewer may realize that the same is true of asthma: A new study suggests the riskiest time for children with asthma is September, as they head back to school.
Mar 10, 2014
0
0
Overweight and obesity are significant risk factors for reduced lung function in school-aged children with a history of early childhood wheezing, according to a study carried out at the University of Eastern Finland. The ...
Jan 2, 2014
0
0
A popular combination asthma therapy dogged by safety concerns has not harmed British Columbians and should remain in use, according to researchers at the University of British Columbia and Vancouver Coastal Health Research ...
Nov 26, 2013
0
0
Teenagers in the child welfare system are at higher-than-average risk of abusing marijuana, inhalants and other drugs, according to a study in the November issue of the Journal of Studies on Alcohol and Drugs.
Nov 4, 2013
0
0
(HealthDay)—Most adults who help children take inhaled asthma medications don't know all of the steps involved for their proper use, new research finds.
Nov 1, 2013
0
0
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids. In a study published today in the journal Nature Communications, researchers from the RIKEN Center for Integrative Medical ...
Oct 25, 2013
0
0
(Medical Xpress)—The availability, pricing and affordability of three essential asthma medicines varies greatly according to a new study of 52 low-and middle-income countries
Oct 16, 2013
0
0
A University of Alberta researcher says health professionals should be cautious about prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, citing a twofold risk for repeat infection.
Sep 18, 2013
0
0
